DCGI

ନୂଆଦିଲ୍ଲୀ: ଭାରତୀୟ ଡ୍ରଗ୍ସ ନିୟାମକ (ଡିସିଜିଆଇ)ର ଏକ୍ସପର୍ଟ କମିଟି (ଏସ୍ଇସି) ଭାରତ ବାୟୋଟେକର ନାସାଲ ଟିକାକୁ ବୁଷ୍ଟର ଡୋଜ୍ ଭାବେ ମଞ୍ଜୁରି ଦେଇଛି | ବୁଧବାର ଏ ବାବଦରେ ଅନୁଷ୍ଠିତ ଗୁରୁତ୍ୱପୂର୍ଣ୍ଣ ବୈଠକରେ ଏକ୍ସପର୍ଟ କମିଟି ଏହି ନାସାଲ୍ ଟିକାର ତୃତୀୟ ପର୍ଯ୍ୟାୟ ଟ୍ରାଏଲ୍ ପାଇଁ…

New Delhi:  Amid growing concern over the new Covid variant Omicron, Hyderabad-based vaccine manufacturer Bharat Biotech's Covaxin on Saturday got approval from the Drug Controller General of India (DGCI) for emergency use for children aged…

New Delhi:  The Drugs Controller General of India (DGCI) has granted emergency use authorisation to Truenat, a real-time PCR platform manufactured by Goa-based Molbio Diagnostics, for testing people infected with Nipah virus. This is the…

New Delhi:  The Drugs Controller General of India (DCGI) has given the approval to conduct a study on mixing of Covishield and Covaxin vaccines. The step has been taken to boost the mass vaccination drive against the coronavirus across the…

New Delhi: The All India Institute of Medical Sciences (AIIMS) Delhi will start clinical trials of Bharat Biotech's Covaxin for the 6-12 age group from Tuesday to evaluate the safety and efficacy of COVID-19 vaccine on children. The…

New Delhi: The Serum Institute of India (SII) has received the permission of the Drugs Controller General of India (DCGI) to manufacture its COVID-19 vaccine 'Covishield', according to reports. The permission for manufacture of the…

New Delhi: Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, has now been granted Restricted Emergency Use authorisation by the Drugs Controller General of India (DCGI) based on…